Abstract
AbstractThe WHODrug medicinal information dictionary is a worldwide source of global medicinal information with the aim to facilitate the coding of medications in clinical trials as well as identification of medication-related problems when monitoring patient safety, thereby supporting the development and usage of effective and safe medications. WHODrug contains individual trade names, active ingredients and additional information such as marketing authorisation holder, country of sale, pharmaceutical form and strength. All related medications are linked using a structured WHODrug alphanumeric code, connecting trade names and variation of the ingredient with the active moiety of the ingredient. Medications in WHODrug are classified using the ATC system and clustered into Standardised Drug Groupings, to allow for grouping of medications with one or more properties in common. The built-in data structure and the classification of medications in WHODrug facilitate various ways of aggregating medications for identification and analysis of possible adverse drug reactions. The different information levels in WHODrug are used to explore the relationship between a medication or a class of medications and an adverse event. By using WHODrug in clinical trials and post-marketing safety, accurate and standardised medication information can be achieved globally and allow easy information exchange. To meet the demands of WHODrug users from the pharmaceutical industry, academia and regulatory authorities, it is relevant to keep the dictionary comprehensive, validated and constantly updated on a global scale.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference22 articles.
1. Babre D. Medical coding in clinical trials. Perspect Clin Res. 2010;1(1):29–32.
2. Lu Z. Technical challenges in designing post-marketing eCRFs to address clinical safety and pharmacovigilance needs. Contemp Clin Trials. 2010;31(1):108–18.
3. Nair GJ. Ensuring quality in the coding process: a key differentiator for the accurate interpretation of safety data. Perspect Clin Res. 2013;4(3):181–5.
4. FDA. FDA Data Standards Catalog v5.2 (12-20-2018). In. https://www.fda.gov/industry/fda-resources-data-standards/study-data-standards-resources: FDA.
5. PMDA. Notification on Practical Operations of Electronic Study Data Submissions In: Bureau PaFS, ed. https://www.pmda.go.jp/english/review-services/reviews/0002.html: PMDA; 2019.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献